Changes to our company portfolio – MSD and Organon & Co. read more

Changes to our company portfolio

Please note that as of June 3rd 2021, MSD completed the spin-off of products from its women’s health, legacy brands, and biosimilars franchises into the new independent, publicly traded company Organon & Co.

For information on former MSD products now transferred to Organon & Co. please visit their website.



Two Names; One

Company & Mission

We are legally called MSD here in the UK and in other parts of the world, but are known as Merck & Co., Inc., Kenilworth NJ, USA, in America and Canada.

LEARN MORE

Top Employer 2021

For the 4th year running - MSD is delighted to have again been recognised for excellence in employee conditions

LEARN MORE

MSD is proud to be investing in the UK.

MSD announces location of new state-of-the-art Discovery Research Centre and UK Headquarters in Central London

LEARN MORE

Addressing antibiotic resistance is more critical than ever. Here’s why.

LEARN MORE

How MSD is responding to the global pandemic, COVID-19

LEARN MORE

Learn about how we invent together

Portraits of Invention tells the story of how our people and heritage at MSD enable us to continue ‘Inventing Together’

WATCH OUR CAMPAIGN HERE

GB-NON-04299
Date of Preparation: May 2021